Monitor the stock price closely over the next 180 days — if BYSI cannot sustain a market cap above $35M for 10 consecutive trading days by March 29, 2027, delisting becomes imminent. The concurrent ATM offering will likely pressure the stock further, making compliance more difficult. Any reverse-split or capital-restructuring announcement would be a critical catalyst.
Price Chart
Executive Summary
BeyondSpring received a Nasdaq deficiency notice on September 29, 2026, for failing to maintain a minimum $35 million market value of listed securities (MVLS) for 30 consecutive business days. The company has a 180-day cure period until March 29, 2027, to regain compliance, but this comes just three days after filing a $11.9 million at-the-market equity offering, signaling severe financial distress and a high risk of eventual delisting.
Key Facts
- Nasdaq notified BeyondSpring on September 29, 2026, that its MVLS fell below $35 million for 30 consecutive business days, violating Listing Rule 5550(b)(2).
- The company has 180 calendar days, until March 29, 2027, to regain compliance by closing at $35M+ MVLS for 10 consecutive business days.
- Three days prior (September 29, 2026), BeyondSpring filed a 424B5 prospectus supplement for an at-the-market offering of up to $11,942,800 in ordinary shares via Citizens JMP Securities.
- The last reported stock price on September 25, 2026, was $0.7772 per share; the public float was approximately $41.8 million as of August 3, 2026.
- Failure to regain compliance by March 29, 2027, will result in a delisting notice, subject to appeal.
Financial Impact
MVLS deficiency threshold is $35 million; current public float was ~$41.8M as of August 3, 2026, but stock has since declined to $0.7772, implying a significantly lower market cap. The $11.9M ATM offering adds dilution pressure.
Risk Factors
- Delisting from Nasdaq if MVLS compliance is not regained by March 29, 2027, severely reducing liquidity and institutional ownership.
- Continued dilution from the $11.9M ATM offering further depresses the stock price, creating a negative feedback loop toward delisting.
- No guarantee that the company can regain compliance through operational improvements or capital actions within the cure period.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001171843-26-006371 |
| Document: 0001171843-26-006371-index-headers.html | 0001171843-26-006371 |
| Document: 0001171843-26-006371-index.html | 0001171843-26-006371 |
| Document: 0001171843-26-006371.txt | 0001171843-26-006371 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 20d ago | 8-K | $0.6450 $0.5870 | ▼ −8.99% | ▼ −8.01% | $0.4600 (−28.68%) |
Oct 2, 2026 24d ago | 8-K | $0.7860 $0.6155 | ▲ +21.69% | ▲ +22.11% | $0.4600 (+41.48%) |
Sep 29, 2026 27d ago | 8-K | $0.7733 $0.6923 | ▼ −10.47% | ▼ −12.42% | $0.4600 (−40.51%) |
Sep 29, 2026 27d ago | 424B5 | $0.7733 $0.6923 | ▲ +10.47% | ▲ +12.42% | $0.4600 (+40.51%) |
Sep 18, 2026 5w ago | 8-K | $0.7400 $1.12 | ▼ −51.35% | ▼ −52.37% | $0.4600 (+37.84%) |
Sep 3, 2026 7w ago | DEFA14A | $0.6181 $0.7600 | ▲ +22.96% | ▲ +24.17% | $0.4600 (−25.58%) |
Aug 14, 2026 10w ago | 8-K | $0.7115 $0.7092 | ▼ −0.32% | ▲ +0.87% | $0.4600 (−35.35%) |
Aug 14, 2026 10w ago | Press Release | $0.7115 $0.7092 | ▼ −0.32% | ▲ +0.87% | $0.4600 (−35.35%) |
Jun 4, 2026 20w ago | 8-K | $1.71 $1.65 | ▼ −3.51% | ▼ −0.96% | $0.4600 (−73.10%) |
Jun 2, 2026 20w ago | Press Release | $1.70 $1.72 | ▲ +1.18% | ▲ +4.14% | $0.4600 (−72.94%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers